Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Saline for injection
DRUG
2 trials
Sponsors
Idera Pharmaceuticals, Inc.
, Liverpool School of Tropical Medicine
Conditions
Actively Extending Plaque Psoriasis
Moderate to Severe Plaque Psoriasis
Streptococcus Pneumonia
Phase 2
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Completed
NCT01622348
Idera Pharmaceuticals, Inc.
Actively Extending Plaque Psoriasis, Moderate to Severe Plaque Psoriasis
Start: 2012-05-31
End: 2012-12-31
Updated: 2018-01-09
Phase 4
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
NCT04974294
Liverpool School of Tropical Medicine
Streptococcus Pneumonia
Start: 2021-07-28
End: 2023-12-31
Target: 516
Updated: 2023-01-05
Related Papers
Evaluation of the effect of serotype on pneumococcal conjugate vaccine-induced immunity: an exploratory analysis of the PREVENTING PNEUMO 2 trial.
2026-09-15
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
BMJ Open
2022-07-01
4 citations